EP2162740A4 - Identification of oxidatively modified peptide sequences in the proteome - Google Patents

Identification of oxidatively modified peptide sequences in the proteome

Info

Publication number
EP2162740A4
EP2162740A4 EP08767687A EP08767687A EP2162740A4 EP 2162740 A4 EP2162740 A4 EP 2162740A4 EP 08767687 A EP08767687 A EP 08767687A EP 08767687 A EP08767687 A EP 08767687A EP 2162740 A4 EP2162740 A4 EP 2162740A4
Authority
EP
European Patent Office
Prior art keywords
proteome
identification
peptide sequences
modified peptide
oxidatively modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP08767687A
Other languages
German (de)
French (fr)
Other versions
EP2162740A1 (en
Inventor
Joseph Loscalzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of EP2162740A1 publication Critical patent/EP2162740A1/en
Publication of EP2162740A4 publication Critical patent/EP2162740A4/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP08767687A 2007-05-15 2008-05-14 Identification of oxidatively modified peptide sequences in the proteome Ceased EP2162740A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93806907P 2007-05-15 2007-05-15
PCT/US2008/006150 WO2008143873A1 (en) 2007-05-15 2008-05-14 Identification of oxidatively modified peptide sequences in the proteome

Publications (2)

Publication Number Publication Date
EP2162740A1 EP2162740A1 (en) 2010-03-17
EP2162740A4 true EP2162740A4 (en) 2010-08-04

Family

ID=40088689

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08767687A Ceased EP2162740A4 (en) 2007-05-15 2008-05-14 Identification of oxidatively modified peptide sequences in the proteome

Country Status (7)

Country Link
US (1) US20080299542A1 (en)
EP (1) EP2162740A4 (en)
JP (1) JP2010527449A (en)
AU (1) AU2008255022A1 (en)
CA (1) CA2684948A1 (en)
IL (1) IL202059A0 (en)
WO (1) WO2008143873A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2620075C (en) * 2005-08-26 2015-03-17 Monsanto Technology Llc High throughput screening of fatty acid composition
JP4998230B2 (en) * 2007-11-26 2012-08-15 株式会社島津製作所 Method for analyzing the oxidation state of methionine residues in protein samples
EP2510361A4 (en) * 2009-12-11 2013-07-17 Purdue Research Foundation Detection of oxidized polypeptides
JP5864312B2 (en) * 2012-03-13 2016-02-17 株式会社島津製作所 Mass spectrometry of S-nitroso substances
CN115078574A (en) * 2022-06-09 2022-09-20 南京科络思生物科技有限公司 Cysteine sulfhydrylation modification method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102744A1 (en) * 2000-10-27 2002-08-01 Snyder Solomon H. Method for assaying protein nitrosylation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003530130A (en) * 2000-04-14 2003-10-14 メタボロン インコーポレイテッド Methods for drug discovery, disease treatment and diagnosis using metabolomics
AU2001259330A1 (en) * 2000-05-02 2001-11-12 Mitokor Proteomic determination of protein nitrotyrosine modifications using mass spectrometry
US7358043B2 (en) * 2001-10-16 2008-04-15 Duke University Proteomic interaction and genomic action determinations in the presence of associated redox state conditions
EP1769088A2 (en) * 2004-06-30 2007-04-04 Whitehead Institute For Biomedical Research Novel methods for high-throughput genome-wide location analysis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102744A1 (en) * 2000-10-27 2002-08-01 Snyder Solomon H. Method for assaying protein nitrosylation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FOSTER MATTHEW W ET AL: "S-nitrosylation in health and disease.", TRENDS IN MOLECULAR MEDICINE, vol. 9, no. 4, April 2003 (2003-04-01), pages 160 - 168, XP002584684, ISSN: 1471-4914 *
P. PAOLI ET AL: "Hydrogen Peroxide Triggers the Formation of a Disulfide Dimer of Muscle Acylphosphatase and Modifies Some Functional Properties of the Enzyme", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, no. 45, 2 November 2001 (2001-11-02), pages 41862 - 41869, XP055017896, ISSN: 0021-9258, DOI: 10.1074/jbc.M106886200 *
See also references of WO2008143873A1 *
YANG YI ET AL: "Regulation of the protein disulfide proteome by mitochondria in mammalian cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 104, no. 26, June 2007 (2007-06-01), pages 10813 - 10817, XP002584683, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
US20080299542A1 (en) 2008-12-04
IL202059A0 (en) 2010-06-16
EP2162740A1 (en) 2010-03-17
CA2684948A1 (en) 2008-11-27
WO2008143873A1 (en) 2008-11-27
AU2008255022A1 (en) 2008-11-27
JP2010527449A (en) 2010-08-12

Similar Documents

Publication Publication Date Title
HK1145506A1 (en) Peptides and their use
EP2142572A4 (en) Tgfp-cap peptide and its uses
EP1976864A4 (en) Novel peptide and use thereof
GB0712670D0 (en) Isolated peptides and uses thereof
EP2172475A4 (en) Novel lipid peptide and hydrogel
EP2318429A4 (en) Prominin-1 peptide fragments and uses thereof
HRP20150195T1 (en) Peptides and their use
GB0702022D0 (en) Peptides and their use
GB0723712D0 (en) Peptides
IL195525A0 (en) Replikin peptides and uses thereof
EP2123666A4 (en) Peptide
IL202059A0 (en) Identification of oxidatively modified peptide sequences in the proteome
EP2285827A4 (en) Peptides and uses thereof
EP2239267A4 (en) Tag peptide and use thereof
GB0724953D0 (en) Methods of peptide modification
GB0703945D0 (en) Peptide
EP2188305A4 (en) Modified peptides having toxin-enhancing effects
IL197675A0 (en) Peptides
GB0617564D0 (en) Peptides and methods
EP2097439A4 (en) Novel peptides
GB0708529D0 (en) Peptide standards
EP2244725A4 (en) Novel peptides and protein and uses thereof
GB0703793D0 (en) Signature peptide identification
IL192800A0 (en) Fgf2-binding peptides and uses thereof
PL383574A1 (en) New protein and sequence encoding it

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100702

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100806

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20131001